Park Ha Biological Technology Co., Ltd.
PHH
$0.57
-$0.0107-1.84%
NASDAQ
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 40.58% | 40.58% | -37.81% | -37.81% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 40.58% | 40.58% | -37.81% | -37.81% | |
| Cost of Revenue | -47.74% | -47.74% | -21.44% | -21.44% | |
| Gross Profit | 58.78% | 58.78% | -39.45% | -39.45% | |
| SG&A Expenses | 86.76% | 86.76% | 15.83% | 15.83% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 42.25% | 42.25% | 9.16% | 9.16% | |
| Operating Income | 38.67% | 38.67% | -86.31% | -86.31% | |
| Income Before Tax | 38.93% | 38.93% | -86.25% | -86.25% | |
| Income Tax Expenses | 78.13% | 78.13% | -75.03% | -75.03% | |
| Earnings from Continuing Operations | 21.98% | 21.98% | -90.20% | -90.20% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 21.98% | 21.98% | -90.20% | -90.20% | |
| EBIT | 38.67% | 38.67% | -86.31% | -86.31% | |
| EBITDA | 38.19% | 38.19% | -84.87% | -84.87% | |
| EPS Basic | 22.86% | 22.86% | -90.00% | -90.00% | |
| Normalized Basic EPS | 39.68% | 39.68% | -85.88% | -85.88% | |
| EPS Diluted | 22.86% | 22.86% | -90.00% | -90.00% | |
| Normalized Diluted EPS | 39.68% | 39.68% | -85.88% | -85.88% | |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |